SELLAS Life Sciences Group, Inc.

NASDAQ:SLS

Biotechnology

Healthcare
$17.95 +4.02%

+$0.31 today

Market cap
$3.66B
Beta
2.53
P/E (TTM)
-47.3
EPS (TTM)
-$0.17
52W Low $1.39High $9.51

Volume 35.53M

Average 7.79M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$28.27M

FY 2025 · Annual

Net Income

-$26.86M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue7.6M1M000
Cost of Revenue200K100K000
Gross Profit7.4M900K000
Gross Margin97.4%90.0%———
Research & Development21.37M30.27M24.01M19.1M16.02M
Selling, General & Admin11.32M12.58M13.86M12.42M12.25M
Operating Expenses32.69M42.85M37.87M31.51M28.27M
Depreciation & Amortization1.27M457K37.87M31.51M0
EBITDA(18.32M)(31.49M)529K632K(26.86M)
EBITDA Margin-241.1%-3149.3%———
Operating Income(25.29M)(41.95M)(37.87M)(31.51M)(28.27M)
Operating Margin-332.8%-4195.0%———
Interest Income6K317K525K632K1.41M
Interest Expense00000
Other Income / Expenses4.36M649K529K632K1.41M
Income Before Tax(20.94M)(41.3M)(37.34M)(30.88M)(26.86M)
Pre-Tax Margin-275.5%-4130.1%———
Income Tax Expense(237K)0000
Net Income(20.7M)(41.3M)(37.34M)(30.88M)(26.86M)
Net Margin-272.4%-4130.1%———
EPS (Basic)(1.34)(2.13)(1.34)(0.50)(0.25)
EPS (Diluted)(1.34)(2.13)(1.34)(0.50)(0.25)
Weighted Avg Shares15.48M19.4M27.78M61.2M109.05M
Weighted Avg Shares (Diluted)15.48M19.4M27.78M61.2M109.05M

SLS Earnings Waterfall · TTM

NASDAQ:SLS · Revenue to Net Income

Key Ratios

EPS$-0.20
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-44.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$35.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.20, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
10-QQuarterly reportAug 11, 2026

How much revenue does SLS generate?

SELLAS Life Sciences Group, Inc. (SLS) reported $0.00 of revenue in fiscal 2025.

Is SLS profitable?

SELLAS Life Sciences Group, Inc. (SLS) reported -$26.86M of net income.